Background Flavonoid metabolites remain in blood for periods of time potentially long enough to allow interactions with cellular components of this tissue. It is well-established that flavonoids are metabolised within the intestine and liver into methylated, sulphated and glucuronidated counterparts, which inhibit platelet function. Methodology/Principal Findings We demonstrate evidence suggesting platelets which contain metabolic enzymes, as an alternative location for flavonoid metabolism. Quercetin and a plasma metabolite of this compound, 4′-O-methyl quercetin (tamarixetin) were shown to gain access to the cytosolic compartment of platelets, using confocal microscopy. High performance liquid chromatography (HPLC) and mass spectrometry (MS) showed that quercetin was transformed into a compound with a mass identical to tamarixetin, suggesting that the flavonoid was methylated by catechol-O-methyl transferase (COMT) within platelets. Conclusions/Significance Platelets potentially mediate a third phase of flavonoid metabolism, which may impact on the regulation of the function of these cells by metabolites of these dietary compounds.
Platelet-Mediated Metabolism of the Common Dietary Flavonoid, Quercetin
Bernice Wright,T. Gibson,J. Spencer,J. Lovegrove,J. Gibbins
Published 2010 in PLoS ONE
ABSTRACT
PUBLICATION RECORD
- Publication year
2010
- Venue
PLoS ONE
- Publication date
2010-03-12
- Fields of study
Biology, Medicine, Chemistry
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-33 of 33 references · Page 1 of 1
CITED BY
Showing 1-48 of 48 citing papers · Page 1 of 1